박병탁 기자

Park Pyeongtak

Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail ppt@kormedi.com

Latest Articles

Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars

Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

[Reporter’s Notebook] Hanmi Group’s Internal Feuds Keep Invoking the ‘Lim Sung-ki Spirit.’ It Must Apply to Everyone

Celltrion Chairman Seo Jung-jin Forgoes Summer Vacation for Global Business Tour Targeting Record Second Half

Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4

HK inno.N's K-CAB Secures Sixth Indication to Prevent Ulcers from Long-Term NSAID Use

Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

Previous34567Next